Ligand Pharmaceuticals (NASDAQ:LGND) has priced $400 million in 0.75% convertible senior notes due 2030 in a private placement to qualified institutional buyers.
Buyers have a 13-day option to purchase up to $60 million more. The sale is expected to close on August